Literature DB >> 31378596

Microwave-Assisted Organic Synthesis, structure-activity relationship, kinetics and molecular docking studies of non-cytotoxic benzamide derivatives as selective butyrylcholinesterase inhibitors.

Sheeba Wajid1, Asma Khatoon1, Maria Aqeel Khan1, Humaira Zafar2, Shama Kanwal1, M Iqbal Choudhary3, Fatima Z Basha4.   

Abstract

A series of benzamide derivatives 1-12 with various functional groups (-H, -Br, -F, -OCH3, -OC2H5, and -NO2) was synthesized using an economic, and facile Microwave-Assisted Organic Synthesis, and evaluated for acetylcholinesterase (ACHE) and butyrylcholinesterase (BCHE) activity in vitro. Structure-activity relationship showed that the substitution of -Br group influenced the inhibitory activity against BCHE enzyme. Synthesized compounds were found to be selective inhibitors of BCHE. In addition, all compounds 1-12 were found to be non-cytotoxic, as compared to the standard cycloheximide (IC50 = 0.8 ± 0.2 µM). Among them, compound 3 revealed the most potent BCHE inhibitory activity (IC50 = 0.8 ± 0.6 µM) when compared with the standard galantamine hydrobromide (IC50 = 40.83 ± 0.37 µM). Enzyme kinetic studies indicated that compounds 1, 3-4, and 7-8 showed a mixed mode of inhibition against BCHE, while compounds 2, 5-6 and 9 exhibited an uncompetitive pattern of inhibition. Molecular docking studies further highlighted the interaction of these inhibitors with catalytically important amino acid residues, such as Glu197, Hip438, Phe329, and many others.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Acetylcholinesterase; Alzheimer disease; Benzamides; Butyrylcholinesterase; Enzyme inhibition; Green chemistry; Microwave-Assisted Organic Synthesis

Year:  2019        PMID: 31378596     DOI: 10.1016/j.bmc.2019.07.015

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  1 in total

1.  New benzamide derivatives and their nicotinamide/cinnamamide analogs as cholinesterase inhibitors.

Authors:  Mehmet Koca; Sinan Bilginer
Journal:  Mol Divers       Date:  2021-06-24       Impact factor: 2.943

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.